Topic: Sustiva
Bristol-Myers Squibb(BMS) and the National AIDS Fund launched the 3rd annual " Bristol-Myers Squibb is a major pharmaceutical company whose mission statement includes: Bristol-Myers Squibb developed, manufactures, and sells several life-saving antiretroviral medications to treat HIV and AIDS: The National AIDS Fund ...
VIENNA (Reuters) - Two pivotal trials of a Johnson & Johnson experimental HIV drug found it worked as well as an existing drug, with fewer side effects but also with nearly twice as many patients failing to respond to treatment.The drug, rilpivirine ...
LOS ANGELES (Reuters) - Drug makers Gilead Sciences Inc and Johnson & Johnson on Thursday said they plan to develop the second once-daily pill for treating HIV, the virus that causes AIDs.The deal was widely expected, but is nevertheless a coup for ...
Two HIV drugs approved last year for patients who have developed resistance to older drugs also work well in new patients, and with fewer troubling side effects than a widely used regimen, according to the drugs' makers.Late-stage, company-funded studies on the drugs, ...
8/3/2008 Print E-mail New guidelines for treating HIV and AIDS patients with treatments known as antiretrovirals suggest earlier therapy might be effective.. The findings were slated to be presented at the International AIDS Conference in Mexico City Sunday. They will also appear ...
FDA officials Wednesday announced approval of a new three-drug combination pill that could mean a single pill a day for many HIV/AIDS patients.. Andrew von Eschenbach, MD, acting commissioner of the FDA, called the drug's introduction a "landmark" in the treatment of ...
